DDInter350 DDInter875
A nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and nonmalignant diseases. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.
Chlorambucil {u} (Compound) resembles {v} (Compound) Melphalan
Chlorambucil {u} (Compound) treats {v} (Disease) ovarian cancer
Chlorambucil {u} (Compound) binds {v} (Gene) SLCO1A2
Chlorambucil {u} (Compound) upregulates {v} (Gene) DDB2
Chlorambucil {u} (Compound) is included by {v} (Pharmacologic Class) Alkylating Activity
Chlorambucil {u} (Compound) downregulates {v} (Gene) CENPA
Chlorambucil {u} (Compound) causes {v} (Side Effect) Hyperuricaemia
Chlorambucil (Compound) resembles Melphalan (Compound)
Chlorambucil (Compound) treats ovarian cancer (Disease)
Chlorambucil (Compound) binds SLCO1A2 (Gene)
Chlorambucil (Compound) upregulates DDB2 (Gene)
Chlorambucil (Compound) is included by Alkylating Activity (Pharmacologic Class)
Chlorambucil (Compound) downregulates CENPA (Gene)
Chlorambucil (Compound) causes Hyperuricaemia (Side Effect)